Clinical Research Directory

Inclusion Criteria: 1. 18 years of age or older; 2. TASC-II aortoiliac lesion classification of modified class A, B, C, or D; 3. Rutherford classification score of 2 to 5; 4. Access site compatibility with the device delivery system; 5. Compliance with the device's instructions for use (IFU); 6. Patient availability for appropriate follow-up times for the duration of the study; 7. Patient informed about the nature of the study, agreeing to its provisions, and signing the informed consent form. Exclusion Criteria: 1. Known hypersensitivity to heparin, contrast media, or stent components; 2. Patient with blood dyscrasia; 3. Pregnant or breastfeeding women; 4. Patient currently participating in an investigational drug or device study; 5. Patient undergoing chemotherapy or radiation therapy; 6. Patient with a stent or graft located in the target limb; 7. Patient who underwent angioplasty or bypass surgery within 30 days prior to inclusion in this study; 8. Patient with a life expectancy of less than 12 months; 9. Inability to undergo dual antiplatelet therapy (DAPT)